Redmont Capital
3
6M
3
0.12
2
- Areas of investment
Summary
Redmont Capital is the famous VC, which was founded in 1998. The leading representative office of defined VC is situated in the Birmingham. The fund was located in North America if to be more exact in United States.
The standard case for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Truffle Capital, Novartis Venture Fund, HealthCap. In the next rounds fund is usually obtained by Biomedical Advanced Research and Development Authority (BARDA).
We also calculated 1 valuable employee in our database.
The higher amount of exits for fund were in 2005. The important activity for fund was in 2015. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 16-20 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Altimmune Among the most successful fund investment fields, there are Test and Measurement, Clinical Trials.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.12
- Investments by industry
- Health Care (2)
- Manufacturing (1)
- Consulting (1)
- Service Industry (1)
- Enterprise Software (1) Show 9 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2008
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 19
- Group Appearance index
- 1.00
- Avg. company exit year
- 9
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Wenzel Spine | 01 Sep 2016 | Surgical Devices, Other Devices and Supplies, Health Care, Health Diagnostics, Medical Device, Medical, Life Science | Early Stage Venture | 3M | United States, Texas, Austin |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.